TARRYTOWN, N.Y., Jan. 27, 2025 /PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results